Raptor Pharmaceutical To Present At Leerink Swann Rare Disease Roundtable

NOVATO, Calif., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced management will present at the Leerink Swann Rare Disease Roundtable in New York on October 2, 2013 at 8:40 a.m. EDT/5:40 a.m. PDT. A live audio webcast and archive of the presentation will be available on the company website at www.raptorpharma.com.

About Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp. is a biopharmaceutical company focused on developing and commercializing life-altering therapeutics that treat rare, debilitating and often fatal diseases. The company's first product, PROCYSBI (cysteamine bitartrate) delayed-release capsules, was approved for the management of nephropathic cystinosis, a rare metabolic lysosomal storage disease, by the FDA in April 2013 and by the EMA in September 2013. Raptor's pipeline also includes RP103 in a Phase 2/3 trial for Huntington's disease and a Phase 2 trial in nonalcoholic fatty liver disease in children. PROCYSBI was granted orphan designation and exclusivity for nephropathic cystinosis in the U.S. and EU and RP103 has received U.S. orphan drug designation for Huntington's disease. For additional information, please visit www.raptorpharma.com.
CONTACT: Georgia Erbez         Chief Financial Officer         Raptor Pharmaceutical Corp.         (415) 408-6231         gerbez@raptorpharma.com                  INVESTOR CONTACTS:         Westwicke Partners, LLC         Stefan Loren, Ph.D.         Managing Director         (443) 213-0507         sloren@westwicke.com         Robert H. Uhl         Managing Director         (858) 356-5932         robert.uhl@westwicke.com                  MEDIA CONTACT:         Carolyn Hawley         Canale Communications         (619) 849-5375         carolyn@canalecomm.com

company logo

More from Press Releases

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX